Minoxidil Market, By Type (5% Minoxidil and 2% Minoxidil), By Route of Administration (Oral and Topical), By Gender (Male and Female), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Latin

Minoxidil Market, By Type (5% Minoxidil and 2% Minoxidil), By Route of Administration (Oral and Topical), By Gender (Male and Female), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Minoxidil Market, By Type (5% Minoxidil and 2% Minoxidil), By Route of Administration (Oral and Topical), By Gender (Male and Female), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Minoxidil is a medication used for the treatment of high blood pressure and pattern hair loss. It is an antihypertensive vasodilator. It is available as a generic medication by prescription in the oral tablet form and over-the-counter as a topical liquid or foam. Minoxidil, an antihypertensive topical formulation, promotes hair growth. Minoxidil is majorly prescribed for the treatment of androgenetic alopecia, and it is also used as an off-label treatment for other hair loss conditions. Minoxidil is a U.S. Food and Drug Administration (FDA) approved, 2% minoxidil solution and was first launched in the market in 1986, followed by the 5% solution in 1993, and it is majorly applicable in hair growth promotion.

Market Dynamics

The increasing adoption of organic growth strategies, such as product launches, by key market players to expand their product portfolios is expected to drive the market growth over the forecast period. For instance, in November 2020, Bosley, the largest hair restoration company in the U.S., launched BosleyRx, the modern-day approach to prescription hair loss medications for men. Through a simple online process, an experienced medical professional can diagnose and prescribe hair loss prevention and growth treatments.

Key features of the study:

• This report provides an in-depth analysis of the global minoxidil market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global minoxidil market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• The key companies covered as a part of this study include Pfizer Inc., Atom pharma, Perrigo Company plc, Johnson and Johnson Services, Inc., Merck KGaA, Actavis Pharma, Inc., Apotex Inc., UltiMed Inc., DS LABORATORIES, INC., Taisho Pharmaceutical Co., Ltd., NIKSAN PHARMACEUTICAL, SALVAVIDAS PHARMACEUTICAL PVT. LTD., Maruti Futuristic Pharma Pvt. Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Lupin, Steris Healthcare PVT Ltd, Salvus Pharma, Unison Pharmaceuticals Pvt Ltd, Par Pharmaceutical, and QndQ Derma
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global minoxidil market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global minoxidil market

Global Minoxidil Market Detailed Segmentation:

• By Type:
• 5% Minoxidil
• 2% Minoxidil
• By Route of Administration:
• Oral
• Topical
• By Gender:
• Male
• Female
• By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• By Region:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa
• Company Profiles
• Pfizer Inc.
• Atom pharma
• Perrigo Company plc
• Johnson and Johnson Services, Inc.
• Merck KGaA
• Actavis Pharma, Inc.
• Apotex Inc.
• UltiMed Inc.
• DS LABORATORIES, INC.
• Taisho Pharmaceutical Co., Ltd.
• NIKSAN PHARMACEUTICAL
• SALVAVIDAS PHARMACEUTICAL PVT. LTD.
• Maruti Futuristic Pharma Pvt. Ltd.
• Sun Pharmaceutical Industries Ltd.
• Reddy’s Laboratories Ltd.
• Lupin
• Steris Healthcare PVT Ltd
• Salvus Pharma
• Unison Pharmaceuticals Pvt Ltd
• Par Pharmaceutical
• QndQ Derma